ClinicalTrials.gg
CompletedNCT05346432Updated Jul 12, 2022

Effects of Lactobacillus Paracasei PS23 on Anti-fatigue

An interventional study of PS23 in Fatigue, sponsored by Chi-Chang Huang. Completed at 1 site in Taiwan. Open to participants aged 20 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-07-12.

Sponsored by Chi-Chang Huang · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 87 studies in Fatigue with a site in Taiwan — 16 open to participants now, 19 under way, 3 of them phase 3. Fatigue · Taiwan.

Enrollment
12th of 71
120 · median 60
Started
2022
with 12 others
No phase
59 of 87
9 open now
Registered
45th of 87
by date

Among the 87 studies in Fatigue with a site in Taiwan, this one is the 12th largest by enrollment of the 71 interventional ones that give a count, is one of 13 that started in 2022, is one of 59 with no phase, and was the 45th registered.

Fatigue

2,234 studies on the registry are indexed under Fatigue; 430 are open to participants now.

Browse Fatigue studies →

Open to participants now

16 of the 87 studies in Fatigue with a site in Taiwan are open now. Recruiting first, the newest first:

11 more — sign in →

All 16 open studies →

A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →

Who these studies take

Of the 242 Fatigue studies recruiting now, 113 (47%) set no upper age limit and 99 (41%) stop at 75 or younger; 23 take children under 18; 74 take healthy volunteers.

This study: 20 Years to 40 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 87 studies in Fatigue with a site in Taiwan, or all of them as a file.
02

Study summary

This research is to explore the effects of supplementing Lactobacillus paracasei PS23 to reduce fatigue and improve physical fitness after exhaustive exercise.

Read the detailed description

Studies have found that the intestinal flora of athletes is different from that of ordinary people, and short-chain fatty acids play a very important role. Previous animal experiments have found that supplementing with specific probiotics can slow down muscle loss in aging mice. In addition, clinical studies have found that supplementing with probiotics can improve sports performance by regulating the intestinal flora and related metabolites. Therefore, the purpose of this research is to explore the effects of supplementing Lactobacillus paracasei PS23 to reduce fatigue and improve physical fitness after exhaustive exercise. This study compares supplementary samples with placebo and adopts a double-blind study design.

03

Conditions studied

  • Fatigue

Browse trials for

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy adult men and women aged 20-40 who are generally non-athletic players

Exclusion criteria

Exclusion Criteria:

  • ≧27
  • Known allergy to probiotics
  • Have current or history of inflammatory bowel disease
  • Patients using of other probiotic products (sachet, capsule or tablet) within the preceding two weeks
  • Those who have taken medication such as anti-inflammatory pain killer or antibiotics in the past one month
  • smoker and alcoholic
  • Who have been injured within 6 months
  • Who has been diagnosed and treated of cardiovascular disease, hypertension, metabolic disease, asthma, or cancer
  • Have undergone surgery of liver, bladder, or gastrointestinal tract
  • Who has conflict of interest with PI
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
120 participants (actual)

Study arms

  • Experimental
    PS23

    The PS23 belongs to Lactobacillus paracasei group, 2 caps daily use.

    Dietary Supplement: PS23

  • Experimental
    heat-treated PS23

    PS23 heat-treated, 2 caps daily use.

    Dietary Supplement: PS23

  • Placebo comparator
    placebo

    The placebo capsule contains microcrystalline cellulose, 2 caps daily use.

    Dietary Supplement: PS23

Interventions

  • Dietary supplementPS23

    PS23 belongs to Lactobacillus paracasei group.Probiotic capsules contain 10 billion CFU (colony forming units) of PS23

06

What researchers measure

Primary outcomes

  1. Stress assessment - difference of Testosterone level

    To assess inflammation indicators, volunteers fasted for at least 8 hours before performing muscle exhaustion exercises. At designated time points in the recovery period, including baseline (0) and 3h, 24h, and 48 after exercise, blood samples were collected with brachial venous catheters. Used commercial kit human Testosterone (Cayman, Mich, USA) and Elisa reader (PerkinElmer, Massachusetts, USA) for analysis Male 265-923 (in ng/dl) Female 15-70 (in ng/dl) for 19 years and older

    Time frame: From Baseline to 6 Weeks Assessed

  2. Difference in Clinical Biochemistry of CK level

    To assess inflammation indicators, volunteers fasted for at least 8 hours before performing muscle exhaustion exercises. At designated time points in the recovery period, blood samples were collected with brachial venous catheters. Assess serum CK(Creatine Kinase, U/L) to monitor physiological fitness. Serum CK (U/L), were assessed for monitoring physiological adaptation. All biochemical indices were assessed using an autoanalyzer (Hitachi 7060, Tokyo, Japan).

    Time frame: From Baseline to 6 Weeks Assessed, including baseline (0) and 3h, 24h, and 48 after exercise

  3. Difference of Muscle damage - blood level of myoglobin

    To assess Muscle damage such as myoglobin (Female:14.3\~65.8, Male:17.4\~105.7) Volunteers fasted for at least 8 hours before performing muscle exhaustion exercises. At designated time points in the recovery period, blood samples were collected with brachial venous catheters. Used commercial kit human myoglobin (Cayman, Mich, USA) and Elisa reader (PerkinElmer, Massachusetts, USA) for analysis

    Time frame: From Baseline to 6 Weeks Assessed, including baseline (0) and 3h, 24h, and 48 after exercise

  4. Oxidative stress assessment - blood of MDA level

    comparing blood levels of oxidative markers such as Malondialdehyde (MDA)

    Time frame: From Baseline to 6 Weeks Assessed

  5. Difference in Oxidative stress - blood level of CRP

    To assess inflammation indicators, volunteers fasted for at least 8 hours before performing muscle exhaustion exercises. At designated time points in the recovery period, blood samples were collected with brachial venous catheters. Used commercial kit human CRP (Cayman, Mich, USA) and Elisa reader (PerkinElmer, Massachusetts, USA) for analysis

    Time frame: From Baseline to 6 Weeks Assessed, including baseline (0) and 3h, 24h, and 48 after exercise

  6. The Countermovement Jump (CMJ) Test

    The CMJ test is a practical, effective, reliable, and simple method of measuring lower limb strength, which is related to the maximum speed, strength and explosive force of the lower limbs. For this test, participants stood on the Kistler force measurement platform (9260AA, Kistler Co., Ltd., Switzerland) on both feet and performed to inspection. During the test, they were asked to put their hands on their hips and remain on the platform. After that, they were asked to squat down until the knees bent 90 degrees and then to immediately jump as high as possible. The average power (MF), were recorded during the jump. Each participant repeated the test 3 times, and CMJ data were obtained at the designated points. The instrument was calibrated for each individual's weight.

    Time frame: From Baseline to 6 Weeks Assessed, In this study, this assessment was performed before and 24 and 48h after the exhaustive exercise program.

  7. The Countermovement Jump (CMJ) Test

    The CMJ test is a practical, effective, reliable, and simple method of measuring lower limb strength, which is related to the maximum speed, strength and explosive force of the lower limbs. For this test, participants stood on the Kistler force measurement platform (9260AA, Kistler Co., Ltd., Switzerland) on both feet and performed to inspection. During the test, they were asked to put their hands on their hips and remain on the platform. After that, they were asked to squat down until the knees bent 90 degrees and then to immediately jump as high as possible. The peak power (Fpeak), were recorded during the jump. Each participant repeated the test 3 times, and CMJ data were obtained at the designated points. The instrument was calibrated for each individual's weight.

    Time frame: From Baseline to 6 Weeks Assessed, In this study, this assessment was performed before and 24 and 48h after the exhaustive exercise program.

  8. The Countermovement Jump (CMJ) Test

    The CMJ test is a practical, effective, reliable, and simple method of measuring lower limb strength, which is related to the maximum speed, strength and explosive force of the lower limbs. For this test, participants stood on the Kistler force measurement platform (9260AA, Kistler Co., Ltd., Switzerland) on both feet and performed to inspection. During the test, they were asked to put their hands on their hips and remain on the platform. After that, they were asked to squat down until the knees bent 90 degrees and then to immediately jump as high as possible. flight time (FT) were recorded during the jump. Each participant repeated the test 3 times, and CMJ data were obtained at the designated points. The instrument was calibrated for each individual's weight.

    Time frame: From Baseline to 6 Weeks Assessed, In this study, this assessment was performed before and 24 and 48h after the exhaustive exercise program.

  9. The Countermovement Jump (CMJ) Test

    The CMJ test is a practical, effective, reliable, and simple method of measuring lower limb strength, which is related to the maximum speed, strength and explosive force of the lower limbs. For this test, participants stood on the Kistler force measurement platform (9260AA, Kistler Co., Ltd., Switzerland) on both feet and performed to inspection. During the test, they were asked to put their hands on their hips and remain on the platform. After that, they were asked to squat down until the knees bent 90 degrees and then to immediately jump as high as possible. The strength development speed (30 ms) were recorded during the jump. Each participant repeated the test 3 times, and CMJ data were obtained at the designated points. The instrument was calibrated for each individual's weight.

    Time frame: From Baseline to 6 Weeks Assessed, In this study, this assessment was performed before and 24 and 48h after the exhaustive exercise program.

  10. Wingate Anaerobic Test (WAnT)

    After a standard warm-up, all subjects were assessed with the classical WAnT on a cycloergometer (Monark 894E, Varberg, Sweden) in a 30 s "go all out" ultramax test. The seat height was adjusted to the satisfaction of each participant, and toe clips prevented the feet from slipping off the pedals. Before the initial test, the subjects warmed up for 5 min, and the power was approximately 50 W. After the warm-up, two preparation exercises lasting 3 s, during which the actual test load was 3% of their own body weight, were applied to accustom the participant to resistance. The test started, and the resistance was set on the friction belt of the dynamometer. External loading was estimated individually at 5% body weight. The recorded results were the relative mean power (W/kg), relative peak power (W/kg), and fatigue index (%). This assessment was performed before and 24 and 72 h after the exhaustive exercise program.

    Time frame: From Baseline to 6 Weeks Assessed

  11. Isometric Mid-Thigh Pull (IMTP)

    Customized IMTP test equipment and two force plates (type 9287BA, Kistler Instruments AG, Winterthur, Switzerland) were used. All participants stood with their feet the same width apart, and the rod was placed between the thighs, with the torso upright, the spine neutral, and the knee and hip angles at 140°, to familiarize the participants with the IMPT test method. The average absolute peak force (PF), relative peak force (N/Kg), rate of force development (RFD), peak rate of force development (pRFD), time to peak force (TPF) and time to peak rate of force development (TPRFD) parameters were recorded. This assessment was performed before and 24 and 48h after the exhaustive exercise program.

    Time frame: From Baseline to 6 Weeks Assessed

  12. Isometric Mid-Thigh Pull (IMTP)

    Customized IMTP test equipment and two force plates (type 9287BA, Kistler Instruments AG, Winterthur, Switzerland) were used. All participants stood with their feet the same width apart, and the rod was placed between the thighs, with the torso upright, the spine neutral, and the knee and hip angles at 140°, to familiarize the participants with the IMPT test method. The average absolute peak force (PF) were recorded.

    Time frame: From Baseline to 6 Weeks Assessed. This assessment was performed before and 24 and 48h after the exhaustive exercise program.

  13. Isometric Mid-Thigh Pull (IMTP)

    Customized IMTP test equipment and two force plates (type 9287BA, Kistler Instruments AG, Winterthur, Switzerland) were used. All participants stood with their feet the same width apart, and the rod was placed between the thighs, with the torso upright, the spine neutral, and the knee and hip angles at 140°, to familiarize the participants with the IMPT test method. The average absolute peak rate of force development (RFD) parameters were recorded.

    Time frame: From Baseline to 6 Weeks Assessed. This assessment was performed before and 24 and 48h after the exhaustive exercise program.

Secondary outcomes

  1. Gut microbiota

    Collect the DNA of fecal flora to test the diversity and abundance of gut microbiota in Stool samples before and after probiotics

    Time frame: From Baseline to 6 Weeks Assessed

  2. Change in Perceived Stress Scale (PSS) Score From Baseline to Change in Perceived Stress Scale (PSS)

    The PSS scores is a rating tool used to gauge the course of stree. The minimum total score possible is 0 and the maximum total score possible is 40. Higher values represent a worse outcome.

    Time frame: From Baseline to 6 Weeks Assessed

  3. Differences in the The Profile of Mood States (POMS) before and after probiotics consumption

    The Profile of Mood States (POMS) is a psychological rating scale used to assess transient, distinct mood states. The Chinese version POMS measures six different dimensions of mood swings over a period of time. These include: Tension or Anxiety, Anger or Hostility, Vigor or Activity, Fatigue or Inertia, Depression or Dejection, Confusion or Bewilderment. A four-point scale ranging from "not at all" to "extremely" is administered by experimenters to patients to assess their mood states.

    Time frame: From Baseline to 6 Weeks Assessed

  4. The Quality of Life, Enjoyment, and Satisfaction Questionnaire-16, QLESQ-16

    The Quality of Life, Enjoyment, and Satisfaction Questionnaire-16 (QLESQ-16) is a valid, reliable self-report instrument for assessing quality of life.

    Time frame: From Baseline to 6 Weeks Assessed

  5. Visual Analogue Scale-GI (VAS-GI)

    Visual Analogue Scale (VAS) consists of a line, 10 cm in length. Individuals point to or mark a spot on the line where they feel indicates their current their emotion, fatigue level and sleep quality. The score of emotion level is from 0cm (very nervous) to 10 cm (very relaxing). The score of fatigue level is from 0 cm (very energetic) to 10 cm (very sleepy). The score of sleep quality is from 0 cm (poor) to 10 cm (sleep well). The maximum total score is 100% (equal 10cm).

    Time frame: From Baseline to 6 Weeks Assessed

  6. Change in Patient Global Impression of Change (PGIC)

    The PGIC consists of one item taken from the clinical global impression and adapted to the patient. The minimum total score possible is 1 and the maximum total score possible is 7. Higher values represent a worse outcome.

    Time frame: From Baseline to 6 Weeks Assessed

  7. Safety assessment - AST

    Safety is assessed function of liver and kidney such as AST (8-38 IU/L).

    Time frame: From Baseline to 6 Weeks Assessed

  8. Safety assessment - ALT

    Safety is assessed function of liver and kidney such as ALT (4-44 IU/L).

    Time frame: From Baseline to 6 Weeks Assessed

  9. Safety assessment - T-Cholesterol

    Safety is assessed function of liver and kidney such as T-Cholesterol (\<170 mg/dL).

    Time frame: From Baseline to 6 Weeks Assessed

  10. Safety assessment - Uric Acid

    Safety is assessed function of liver and kidney such as Uric Acid (3.4-7.6 mg/dl)

    Time frame: From Baseline to 6 Weeks Assessed

  11. Safety assessment - Bun

    Safety is assessed function of liver and kidney such as Bun (6-20 mg/dl)

    Time frame: From Baseline to 6 Weeks Assessed

  12. Safety assessment - Creatinine

    Safety is assessed function of liver and kidney such as Creatinine (0.6-1.3 mg/dl)

    Time frame: From Baseline to 6 Weeks Assessed

  13. Safety assessment - Glucose

    Safety is assessed function of liver and kidney such as Glucose (70\~100 mg/dL)

    Time frame: From one week before Baseline to 6 Weeks Assessed

  14. Safety assessment - Triglycerides

    Safety is assessed function of liver and kidney such as Triglycerides (\<150 mg/dL)

    Time frame: From Baseline to 6 Weeks Assessed

  15. Safety assessment - LDL

    Safety is assessed function of liver and kidney such as LDL (0\~140mg/dl)

    Time frame: From Baseline to 6 Weeks Assessed

  16. Safety assessment - HDL

    Safety is assessed function of liver and kidney such as HDL (\>40mg/dl)

    Time frame: From Baseline to 6 Weeks Assessed

07

Study locations

1 site
  • National Taiwan Sport University
    Taoyuan, 333, Taiwan
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2022 to primary completion in Jul 2022, 2 months.

Of 937 non-industry interventional studies with no phase under Fatigue, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 27. This study's 2 months is below that.

Counting every sponsor, half of 990 studies reached it within 12 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 24, 2022
First posted
Apr 26, 2022
StartActual
May 1, 2022
Primary completionActual
Jul 10, 2022
CompletionActual
Jul 10, 2022
Last update
Jul 12, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 12, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05346432
Lead sponsor
Chi-Chang Huang
Collaborators
Bened Biomedical Co., Ltd.
Responsible party
Chi-Chang Huang (Principal Investigator, National Taiwan Sport University) — Sponsor-investigator
First posted
Apr 26, 2022
Start date
May 1, 2022
Primary completion
Jul 10, 2022
Completion
Jul 10, 2022
Last update
Jul 12, 2022

Study contacts

Chi-Chang Huang, Ph.D
principal investigator · National Taiwan Sport University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: PS23

Start the discussion